...
首页> 外文期刊>Cytotechnology >Clinical application of the SurePath liquid-based Pap test in cytological screening of bronchial brushing for the diagnosis of lung cancer
【24h】

Clinical application of the SurePath liquid-based Pap test in cytological screening of bronchial brushing for the diagnosis of lung cancer

机译:SurePath液基Pap检测在支气管涂刷细胞学筛查中的临床诊断肺癌

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The SurePath liquid-based Pap test (LPT) is successfully and widely used to assess sputum cytology. This study aimed to compare the cytological findings and diagnostic sensitivity of LPT with those of the conventional Pap smear (CPS) method for diagnosing lung cancer. Bronchial brushing specimens from 204 patients diagnosed with lung cancer were studied. LPT slides showed decreased areas of cell monolayers, a clearer background and distinct, stereoscopic cytological features. The LPT had a significantly higher diagnostic sensitivity for lung cancer (71.6%) than the CPS method (57.8%, p 2 cm lesions (p 2 cm lesions (81.4%) compared with the CPS method alone (p < 0.05, p < 0.01). Thus, LPT is a useful and easily performed technique that can be widely applied, and is suitable for the early diagnosis of lung cancer.
机译:SurePath基于液体的巴氏试验(LPT)已成功且广泛用于评估痰细胞学检查。这项研究的目的是将LPT的细胞学发现和诊断敏感性与常规的子宫颈抹片涂片(CPS)诊断肺癌的方法进行比较。研究了204名被诊断患有肺癌的患者的支气管刷洗标本。 LPT玻片显示细胞单层面积减少,背景更清晰以及明显的立体细胞学特征。 LPT对肺癌的诊断敏感性(71.6%)比CPS方法(57.8%,p 2 cm病变(p 2 cm病变(81.4%))与仅CPS方法相比(p <0.05,p <0.01 )。因此,LPT是一种有用且易于执行的技术,可以广泛应用,并且适合于肺癌的早期诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号